OneDigital Investment Advisors LLC Buys New Position in Avantor, Inc. $AVTR

OneDigital Investment Advisors LLC purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 142,922 shares of the company’s stock, valued at approximately $1,415,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wellington Management Group LLP acquired a new stake in Avantor in the fourth quarter valued at approximately $268,584,000. Morgan Stanley lifted its position in shares of Avantor by 179.4% during the fourth quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock worth $200,188,000 after purchasing an additional 11,216,565 shares in the last quarter. Engine Capital Management LP lifted its position in shares of Avantor by 65.8% during the first quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock worth $155,082,000 after purchasing an additional 7,853,018 shares in the last quarter. Norges Bank purchased a new position in shares of Avantor in the fourth quarter valued at $73,322,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Avantor in the second quarter valued at $40,800,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of a number of recent analyst reports. Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Wells Fargo & Company upped their price objective on shares of Avantor from $14.00 to $16.00 and gave the company an “overweight” rating in a research report on Thursday, July 30th. Stifel Nicolaus raised their target price on Avantor from $8.00 to $15.00 and gave the company a “hold” rating in a research note on Thursday, July 30th. Wall Street Zen upgraded Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $13.00 price target on shares of Avantor in a research note on Thursday, July 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.00.

Avantor Stock Down 1.0%

Shares of NYSE:AVTR opened at $13.52 on Tuesday. The firm has a market cap of $9.14 billion, a PE ratio of -16.10, a price-to-earnings-growth ratio of 10.29 and a beta of 0.89. The company has a fifty day simple moving average of $11.28 and a 200 day simple moving average of $9.55. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The firm’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, equities research analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.